Bronno van der Holt

Department of Hematology Erasmus MC Cancer Institute

关注

立即认领

关注

立即认领

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 396 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

Predictors of Early Morbidity and Mortality in Newly Diagnosed Multiple Myeloma: Data from Five Randomized, Controlled, Phase III Trials in 3700 Patients

Elias K. Mai,Thomas Hielscher,Uta Bertsch,Hans J. Salwender,Sonja Zweegman,Marc S. Raab,Markus Munder,Lucia Pantani,Katia Mancuso,Peter Brossart,Meral Beksac,Igor W. Blau,Jan Dürig,Britta Besemer,Roland Fenk,Peter Reimer,Bronno van der Holt,Mathias Hänel,Ivana von Metzler,Ullrich Graeven,Carsten Müller-Tidow,Mario Boccadoro,Christof Scheid,Meletios A. Dimopoulos,Jens Hillengass,Katja C. Weisel,Michele Cavo,Pieter Sonneveld,Hartmut Goldschmidt

LEUKEMIAno. 2 (2024): 258-265

引用0浏览0WOSNATURE引用

Teclistamab Impairs Humoral Immunity in Patients with Heavily Pretreated Myeloma: Importance of Immunoglobulin Supplementation

Kristine A. Frerichs,Christie P. M. Verkleij,Maria Victoria Mateos,Thomas G. Martin,Cesar Rodriguez,Ajay Nooka,Arnob Banerjee,Katherine Chastain,Alfredo Perales-Puchalt,Tara Stephenson,Clarissa Uhlar,Rachel Kobos,Bronno van der Holt,Sandy Kruyswijk,Maria T. Kuipers,Kaz Groen,Deeksha Vishwamitra,Sheri Skerget,Diana Cortes-Selva,Margaret Doyle, Hans L. Zaaijer,Sonja Zweegman,Raluca I. Verona,Niels W. C. J. van de Donk

BLOOD ADVANCES（2024）

引用0浏览0WOS引用

Survival, Neurocognitive Function, and Health-Related Quality of Life Outcomes after Rituximab-Methotrexate, BCNU, Teniposide, and Prednisolone for Primary CNS Lymphoma: Final Results of the HOVON 105/ALLG NHL 24 Study

Jacoline E. C. Bromberg,Samar Issa,Bronno van der Holt,Matthijs van der Meulen,Linda Dirven,Monique C. Minnema,Tatjana Seute,Marc Durian,Gavin Cull,Marjolein W. M. van der Poel,Wendy B. C. Stevens,Josee M. Zijlstra,Dieta Brandsma,Marcel Nijland,Kylie D. Mason,Aart Beeker,Martine C. J. Abrahamse-Testroote,Martin J. van den Bent,Daphne de Jong,Jeanette K. Doorduijn

NEURO-ONCOLOGYno. 4 (2024): 724-734

引用0浏览0WOS引用

Benefits and Risks of Clofarabine in Adult Acute Lymphoblastic Leukemia Investigated in Depth by Multi‐state Modeling

Sjoerd J. F. Hermans,Yvette van Norden,Jurjen Versluis,Anita W. Rijneveld,Bronno van Der Holt,Okke de Weerdt,Bart J. Biemond,Arjan A. van de Loosdrecht,Lotte E. van Der Wagen,Mar Bellido,Michel van Gelder,Walter J. F. M. van Der Velden,Dominik Selleslag,Danielle van Lammeren-Venema,Vincent H. J. van Der Velden,Liesbeth C. de Wreede,Douwe Postmus,Francesco Pignatti,Jan J. Cornelissen

CANCER MEDICINE（2024）

引用0浏览0WOS引用

Supplementary Figure S2 from Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial

Lale Erdem-Eraslan,Martin J. van den Bent,Youri Hoogstrate,Hina Naz-Khan,Andrew Stubbs,Peter van der Spek,René Böttcher,Ya Gao,Maurice de Wit,Walter Taal,Hendrika M. Oosterkamp,Annemiek Walenkamp,Laurens V. Beerepoot,Monique C.J. Hanse,Jan Buter,Aafke H. Honkoop,Bronno van der Holt,René M. Vernhout,Peter A.E. Sillevis Smitt,Johan M. Kros,Pim J. French

crossref（2023）

引用0浏览0引用

Supplementary Figure S13 from Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial

crossref（2023）

引用0浏览0引用

Supplementary Table S1 from Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial

crossref（2023）

引用0浏览0引用

Supplementary Figure S1 from Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial

crossref（2023）

引用0浏览0引用

Supplementary Figure S3 from Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial

crossref（2023）

引用0浏览0引用

P20.11.A TEMPORAL MUSCLE THICKNESS AS PROGNOSTIC MARKER IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA - A VALIDATION STUDY

Matthijs van der Meulen,Renske Gahrmann,Bronno van der Holt,Jeanette K. Doorduijn,Samar Issa,Jacoline E C Bromberg

Neuro-oncologyno. Supplement_2 (2023): ii129-ii129

引用0浏览0引用

加载更多

作者统计

#Papers: 397

#Citation: 15334

H-Index: 63

G-Index: 114

Sociability: 8

Diversity: 3

Activity: 50

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn